Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Midecamycin: Mechanism, MICs, and Research Use
2026-08-18
Midecamycin is a 16-membered, acetoxy-substituted macrolide antibiotic and bacterial protein synthesis inhibitor with strongest reported activity against Gram-positive organisms. Its A2058-directed mechanism, glycosylation-sensitive 2''-OH site, MIC benchmarks, solubility limits, and storage requirements define its use as an antibiotic research compound.
-
NET-DNA–CCDC25 Axis in Intestinal Repair
2026-08-18
This FASEB Journal study identifies a mechanistic link between neutrophil extracellular trap DNA, CCDC25 signaling in group 3 innate lymphoid cells, and impaired IL-22-dependent intestinal epithelial repair. Its combination of mouse models, transcriptomics, cell perturbation, and epithelial barrier assays suggests that NET-DNA is not only a marker of ulcerative colitis activity but also an active suppressor of mucosal healing.
-
S-Adenosylhomocysteine in Neural Differentiation Assays
2026-08-17
S-Adenosylhomocysteine enables controlled testing of how methylation potential may intersect with radiation-induced neural differentiation. This workflow combines SAH dosing, SAM/SAH ratio modulation, pathway-resolved readouts, and rescue controls without overstating findings that have not yet been demonstrated in neural cells.
-
DED Assembly Mechanisms in Apoptosis
2026-08-17
The reference study defines atomic features of human FADD–procaspase-8–cFLIP death-effector-domain complexes using X-ray crystallography and cryo-EM. Its structures explain how the same signaling architecture can support limited caspase-8 activity, apoptosis control, and suppression of RIPK1-dependent necroptosis.
-
From Fyn–Stat3 Biology to Precision Gene Editing
2026-08-16
The Fyn–Stat3 axis provides a compelling example of how mechanistic neurodegeneration research can evolve from pathway observation to causal testing. This article outlines how EZ Cap™ Cas9 mRNA (5-moUTP) can support controlled CRISPR-Cas9 genome editing studies in zebrafish and other translational models while keeping experimental interpretation, delivery, and limitations in view.
-
Mitochondrial Permeability Transition Pore Assay Kit
2026-08-15
Turn mitochondrial pore opening into a measurable fluorescence endpoint with a workflow suited to infection, stress, and cell-death models. This guide shows how to combine Calcein retention, cobalt quenching, ionomycin controls, and orthogonal mitochondrial readouts for more defensible mechanism studies.
-
Spermine Workflows for Ion Channel Research
2026-08-14
Use Spermine to build controlled inward-rectifier assays, distinguish polyamine-dependent conductance from magnesium effects, and connect electrophysiology with membrane-organization phenotypes. A practical two-track workflow also shows how the CLCC1 herpesvirus nuclear-egress study can inform assay design without implying a direct Spermine–CLCC1 mechanism.
-
Foretinib: From Kinase Potency to Translation
2026-08-14
Foretinib (GSK1363089) offers translational researchers a way to interrogate convergent Met, VEGFR, and related receptor tyrosine kinase signaling. This article moves beyond potency tables to show how assay design, response decomposition, and metastasis-oriented models can turn a multikinase perturbation into more interpretable cancer biology.
-
N1-Methylpseudouridine for Cardiac mRNA Studies
2026-08-13
Use N1-Methylpseudouridine to build higher-expression, lower-innate-activation mRNA workflows for testing HEY2-driven cardiac metabolic dysfunction. The approach connects controlled mRNA translation enhancement with assays of mitochondrial respiration, oxidative stress, and rescue by PPARGC1A or ESRRA.
-
FLAG tag Peptide: Workflow and Troubleshooting
2026-08-13
The FLAG tag Peptide (DYKDDDDK) supports gentle, competitive elution and sensitive recombinant protein detection without requiring harsh denaturation. This practical guide connects affinity purification with fluorescence, enzymatic, cross-linking, and structural workflows inspired by recent saposin B–α-galactosidase A research.
-
MK-1775: Wee1 Kinase Inhibitor Workflows
2026-08-12
MK-1775 enables controlled studies of Wee1-dependent checkpoint biology, especially in p53-deficient cancer models exposed to DNA damage. This practical guide combines mechanistic validation, paired viability and cell-killing assays, protocol parameters, and troubleshooting strategies for more interpretable results.
-
Storage Optimization for LNP Self-Replicating RNA
2026-08-12
This study systematically examined how temperature, buffer composition, cryoprotection, and lyophilization affect lipid nanoparticle-formulated self-replicating RNA vaccines. Its principal finding was that RNase-free PBS containing 10% sucrose supported preservation of structure and in vivo potency at −20 °C for 30 days, while lyophilization also retained measurable bioactivity.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-08-11
AZD8055 is an ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer-cell proliferation, and related metabolic responses. It is appropriate for mechanistic preclinical workflows, but its poor aqueous solubility, limited clinical benefit, and absence of directly matched paper evidence here require careful formulation and independent validation.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-08-11
K1223 provides an HRP-labeled, affinity-purified reagent for detecting rabbit IgG primary antibodies in Western blot, ELISA, IHC, and IC workflows. It is intended for research use only and should not be treated as a diagnostic reagent or as a universal secondary antibody for non-rabbit immunoglobulins.
-
DHEA in PCOS Models: A Better Assay Logic
2026-08-10
Dehydroepiandrosterone (DHEA) can either protect neural cells or induce a PCOS-like ovarian phenotype, depending on context. This guide explains how to separate those roles and use mitochondrial steroidogenesis readouts for more causal, reproducible experiments.